Objective: To determine primary and acquired resistance to pyrazinamide in Mycobacterium tuberculosis strains isolated in sputum samples from patients with pulmonary tuberculosis.
Methods: This was a prospective, descriptive study conducted between April and November of 2011 at a referral hospital for tuberculosis in the city of Recife, Brazil. Cultures, drug sensitivity tests, and tests of pyrazinamidase activity were conducted in a private laboratory in Recife.
Results: Of the 71 patients included in the study, 37 were treatment-naïve and 34 represented cases of retreatment. Pyrazinamide-resistant strains were isolated in 14 (41.2%) of the 34 patients who had previously been treated for tuberculosis and in none of the 37 treatment-naïve patients. Of the 14 isolates, 10 (90.9%) tested negative for pyrazinamidase activity. A total of 60 isolates tested positive for pyrazinamidase activity. Of those, 56 (93.3%) were found to be sensitive to pyrazinamide.
Conclusions: The high frequency of pyrazinamide-resistant strains (41.2%) in patients previously treated for tuberculosis highlights the need for drug susceptibility testing prior to the adoption of a new treatment regimen.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s1806-37132012000600009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Quantitative MODS-Wayne assay for rapid detection of pyrazinamide resistance in from sputum samples.
Microbiol Spectr
November 2024
Laboratorio de Bioinformática, Biología Molecular y Desarrollos Tecnológicos. Laboratorios de Investigación y Desarrollo. Facultad de Ciencias e Ingeniería. Universidad Peruana Cayetano Heredia, Lima, Peru.
Unlabelled: Tuberculosis (TB) remains a significant global health challenge, exacerbated by the emergence of drug-resistant strains, such as those resistant to pyrazinamide (PZA). The current scarcity of affordable and precise quantitative diagnostic tests for PZA resistance underscores the urgent need for more accessible diagnostic tools. We evaluated PZA susceptibility in 264 TB-positive samples by quantifying pyrazinoic acid (POA) production, using both the MODS-Wayne qualitative assay and our newly developed quantitative approach (MODS-WQ).
View Article and Find Full Text PDFA robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosis.
J Cell Mol Med
April 2024
Bangladesh Council of Scientific and Industrial Research, Dhaka, Bangladesh.
The rise of pyrazinamide (PZA)-resistant strains of Mycobacterium tuberculosis (MTB) poses a major challenge to conventional tuberculosis (TB) treatments. PZA, a cornerstone of TB therapy, must be activated by the mycobacterial enzyme pyrazinamidase (PZase) to convert its active form, pyrazinoic acid, which targets the ribosomal protein S1. Resistance, often associated with mutations in the RpsA protein, complicates treatment and highlights a critical gap in the understanding of structural dynamics and mechanisms of resistance, particularly in the context of the G97D mutation.
View Article and Find Full Text PDFMechanistic insights into the conformational changes and alterations in residual communications due to the mutations in the pncA Gene of Mycobacterium tuberculosis: A computational perspective for effective therapeutic solutions.
Comput Biol Chem
June 2024
Structural Biology and Biocomputing Lab, Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu 630004, India. Electronic address:
Due to its emerging resistance to first-line anti-TB medications, tuberculosis (TB) is one of the most contagious illness in the world. According to reports, the effectiveness of treating TB is severely impacted by drug resistance, notably resistance caused by mutations in the pncA gene-encoded pyrazinamidase (PZase) to the front-line drug pyrazinamide (PZA). The present study focused on investigating the resistance mechanism caused by the mutations D12N, T47A, and H137R to better understand the structural and molecular events responsible for the resistance acquired by the pncA gene of Mycobacterium tuberculosis (MTB) at the structural level.
View Article and Find Full Text PDFExploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3).
Braz J Biol
March 2024
Airlangga University, Faculty of Science and Technology, Department of Chemistry, Surabaya, Indonesia.
Article Synopsis
- The pncA gene mutations in Mycobacterium tuberculosis are linked to resistance against the antibiotic pyrazinamide (PZA), with notable differences between sensitive and resistant strains.
- The study identified three specific mutations in the resistant strain (pncAR1) that altered key amino acids, resulting in decreased enzyme activity for activating PZA.
- The findings suggest a need for further structural studies on the mutated PZase protein to better understand how these mutations contribute to drug resistance and to aid in the design of more effective tuberculosis treatments.
Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Isolates in Hunan, China.
Infect Drug Resist
February 2024
Clinical Laboratory, Hunan Chest Hospital, Changsha, People's Republic of China.
Article Synopsis
- The study focused on the high prevalence of pyrazinamide (PZA) resistance in multidrug-resistant TB (MDR-TB) in Hunan province, China, discovering a PZA resistance rate of 60.4% among tested MDR-TB isolates.
- It utilized drug susceptibility testing and genetic analysis methods on 298 MDR isolates, identifying 98 mutation patterns in PZA-resistant strains, with a significant number being new mutations that could provide insights into drug resistance mechanisms.
- The findings suggest that both DNA sequencing and PZase activity testing are promising tools for predicting PZA resistance in TB strains, highlighting the importance of understanding genetic diversity in effective treatment strategies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!